Efficacy and safety of combined medium-dose mometasone furoate/formoterol (MF/F) in persistent asthmatics
نویسندگان
چکیده
Background The availability of controller therapies at multiple strengths is important to treat different severities of asthma (NHLBI and GINA guidelines). The clinical effect of medium-dose mometasone furoate/formoterol (MF/F) combination administered via single inhaler had never been characterized in asthmatic subjects versus placebo. We investigated the effect of medium-dose MF/F administered via an MDI on asthma deteriorations (ie, severe asthma exacerbations) and pulmonary function in moderately-severe asthmatics inadequatelycontrolled on medium-dose inhaled corticosteroids (ICS) ± long-acting b2-agonists (LABA).
منابع مشابه
Effect of mometasone furoate/formoterol combination therapy on nocturnal awakenings in subjects with persistent asthma
Methods Subjects were asthmatics previously using low(n=746), medium(n=781) or high-dose (n=728) inhaled corticosteroids ICS. Low-dose subjects were randomized to 26-wk treatment with MF/F 100/10μg, MF 100μg, F 10μg, or placebo; medium-dose subjects to 26-wk treatment with MF/F 200/10μg, MF 200μg, F 10μg, or placebo; high-dose subjects to 12-wk treatment with MF/F 400/10μg, MF/F 200/10μg, or MF...
متن کاملEfficacy and safety of medium and high doses of mometasone furoate/formoterol (MF/F) combination treatment in subjects with severe persistent asthma
Materials and methods This was a 3-month, randomized, double-blind, parallelgroup, multicenter study with a 2-3-week open-label, run-in period of mometasone furoate (MF) 400 μg twice-daily (BID). Subjects (≥12 years) were randomized to MF/F (200/10 μg or 400/10 μg BID) or MF (400 μg BID). The primary endpoint was the area under the curve (AUC) of the change in serial FEV1 (0-12 hours) for MF/F ...
متن کامل189 Efficacy and Safety of Two Doses of Mometasone Furoate/Formoterol Combination Treatment in Subjects With Severe Asthma
187 Reduction in Asthma Deteriorations in Subjects with Persistent Asthma not Well Controlled on Low-, Medium-, or High-Dose Inhaled Corticosteroids: A Pooled Analysis From Three Clinical Trials Using Combined Mometasone Furoate/Formoterol Steven Weinstein, MD, Robert Nathan, Eli Meltzer, MD, Davis Gates, and Hendrik Nolte. Allergy & Asthma Specialists Medical Group, Huntington Beach, CA; Asthm...
متن کامل188 Efficacy Comparison of Mometasone Furoate/Formoterol Versus Fluticasone Propionate/Salmeterol Combination Therapies in Subjects With Persistent Asthma: Noninferiority and Onset-of-Action Findings
187 Reduction in Asthma Deteriorations in Subjects with Persistent Asthma not Well Controlled on Low-, Medium-, or High-Dose Inhaled Corticosteroids: A Pooled Analysis From Three Clinical Trials Using Combined Mometasone Furoate/Formoterol Steven Weinstein, MD, Robert Nathan, Eli Meltzer, MD, Davis Gates, and Hendrik Nolte. Allergy & Asthma Specialists Medical Group, Huntington Beach, CA; Asthm...
متن کاملNon-inferiority efficacy comparison of mometasone furoate/formoterol versus fluticasone propionate/salmeterol combination therapies in subjects with persistent asthma
Materials and methods This randomized, active-controlled, multicenter, noninferiority trial enrolled subjects (≥12 yrs) previously treated with medium-dose inhaled corticosteroid alone or combined with a long-acting b2-agonist. Following a 2-4 wk run-in treatment period with MF administered via metered-dose inhaler (MDI) 200 μg twice daily (BID), eligible subjects were randomized to MF/F-MDI 20...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 6 شماره
صفحات -
تاریخ انتشار 2010